A detailed history of Hrt Financial LP transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Hrt Financial LP holds 13,492 shares of ICCM stock, worth $7,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,492
Holding current value
$7,825
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.58 - $0.83 $7,825 - $11,198
13,492 New
13,492 $8,000
Q1 2024

May 13, 2024

SELL
$1.16 - $1.48 $21,816 - $27,834
-18,807 Reduced 50.11%
18,726 $22,000
Q4 2023

Feb 09, 2024

BUY
$0.72 - $1.36 $27,023 - $51,044
37,533 New
37,533 $40,000

Others Institutions Holding ICCM

About IceCure Medical Ltd.


  • Ticker ICCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,835,600
  • Market Cap $21.4M
  • Description
  • IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
More about ICCM
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.